Arch Therapeutics, Inc. Quarterly Operating Income (Loss) in USD from Q2 2012 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: Arch Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2012 to Q2 2024.
Arch Therapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$1.02M, a 0.7% decline year-over-year.
Arch Therapeutics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$4.72M, a 8.43% increase year-over-year.
Arch Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$5.04M, a 11.6% increase from 2022.
Arch Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$5.71M, a 10.5% increase from 2021.
Arch Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$6.38M, a 19.2% decline from 2020.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Quarterly (USD)

Operating Income (Loss), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q2 2024	-$4.72M	-$1.02M	-$7.14K	-0.7%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-19
Q1 2024	-$4.71M	-$877K	+$549K	+38.5%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-09
Q4 2023	-$5.26M	-$1.49M	-$219K	-17.2%	Oct 1, 2023	Dec 31, 2023	10-Q	2024-02-20
Q3 2023	-$5.04M	-$1.33M	+$112K	+7.79%	Jul 1, 2023	Sep 30, 2023	10-K	2024-02-15
Q2 2023	-$5.16M	-$1.01M	-$7.4K	-0.74%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-19
Q1 2023	-$5.15M	-$1.43M	+$325K	+18.6%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-09
Q4 2022	-$5.47M	-$1.28M	+$234K	+15.5%	Oct 1, 2022	Dec 31, 2022	10-Q	2024-02-20
Q3 2022	-$5.71M	-$1.44M	+$284K	+16.4%	Jul 1, 2022	Sep 30, 2022	10-K	2024-02-15
Q2 2022	-$5.99M	-$1.01M	+$661K	+39.6%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-11
Q1 2022	-$6.65M	-$1.75M	-$320	-0.02%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-23
Q4 2021	-$6.65M	-$1.51M	-$276K	-22.4%	Oct 1, 2021	Dec 31, 2021	10-Q	2023-02-14
Q3 2021	-$6.38M	-$1.72M	-$370K	-27.3%	Jul 1, 2021	Sep 30, 2021	10-K	2022-12-28
Q2 2021	-$6.01M	-$1.67M	-$430K	-34.8%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-11
Q1 2021	-$5.58M	-$1.75M	-$596K	-51.6%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-13
Q4 2020	-$4.98M	-$1.23M	+$386K	+23.8%	Oct 1, 2020	Dec 31, 2020	10-Q	2022-02-11
Q3 2020	-$5.37M	-$1.35M	+$169K	+11.1%	Jul 1, 2020	Sep 30, 2020	10-K	2020-12-11
Q2 2020	-$5.54M	-$1.24M	+$335K	+21.3%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-13
Q1 2020	-$5.87M	-$1.15M	+$353K	+23.4%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-06
Q4 2019	-$6.22M	-$1.62M	+$148K	+8.39%	Oct 1, 2019	Dec 31, 2019	10-Q	2021-02-12
Q3 2019	-$6.37M	-$1.52M	+$709K	+31.8%	Jul 1, 2019	Sep 30, 2019	10-K	2020-12-11
Q2 2019	-$7.08M	-$1.57M	+$47.9K	+2.96%	Apr 1, 2019	Jun 30, 2019	10-K	2020-12-11
Q1 2019	-$7.13M	-$1.51M	+$506K	+25.2%	Jan 1, 2019	Mar 31, 2019	10-K	2020-12-11
Q4 2018	-$7.64M	-$1.77M	-$185K	-11.7%	Oct 1, 2018	Dec 31, 2018	10-K	2020-12-11
Q3 2018	-$7.45M	-$2.23M	-$352K	-18.7%	Jul 1, 2018	Sep 30, 2018	10-K	2019-11-19
Q2 2018	-$7.1M	-$1.62M	+$221K	+12%	Apr 1, 2018	Jun 30, 2018	10-K	2019-11-19
Q1 2018	-$7.32M	-$2.01M	+$190K	+8.63%	Jan 1, 2018	Mar 31, 2018	10-K	2019-11-19
Q4 2017	-$7.51M	-$1.58M	-$206K	-15%	Oct 1, 2017	Dec 31, 2017	10-K	2019-11-19
Q3 2017	-$7.3M	-$1.88M	-$97.6K	-5.47%	Jul 1, 2017	Sep 30, 2017	10-K	2018-12-18
Q2 2017	-$7.2M	-$1.84M	-$108K	-6.26%	Apr 1, 2017	Jun 30, 2017	10-K	2018-12-18
Q1 2017	-$7.1M	-$2.2M	-$949K	-75.7%	Jan 1, 2017	Mar 31, 2017	10-K	2018-12-18
Q4 2016	-$6.15M	-$1.38M	-$96.4K	-7.54%	Oct 1, 2016	Dec 31, 2016	10-K	2018-12-18
Q3 2016	-$6.05M	-$1.78M	-$187K	-11.7%	Jul 1, 2016	Sep 30, 2016	10-K	2017-11-15
Q2 2016	-$5.86M	-$1.73M	-$394K	-29.5%	Apr 1, 2016	Jun 30, 2016	10-Q	2017-07-27
Q1 2016	-$5.47M	-$1.25M	+$954	+0.08%	Jan 1, 2016	Mar 31, 2016	10-Q	2017-05-02
Q4 2015	-$5.47M	-$1.28M	-$9.43K	-0.74%	Oct 1, 2015	Dec 31, 2015	10-Q	2017-02-01
Q3 2015	-$5.46M	-$1.6M	-$207K	-14.9%	Jul 1, 2015	Sep 30, 2015	10-K	2016-12-05
Q2 2015	-$5.25M	-$1.34M	-$192K	-16.7%	Apr 1, 2015	Jun 30, 2015	10-Q	2016-07-28
Q1 2015	-$5.06M	-$1.26M	+$39.9K	+3.08%	Jan 1, 2015	Mar 31, 2015	10-Q	2016-04-28
Q4 2014	-$5.1M	-$1.27M	-$489K	-62.7%	Oct 1, 2014	Dec 31, 2014	10-Q	2016-02-12
Q3 2014	-$4.61M	-$1.39M	-$428K	-44.5%	Jul 1, 2014	Sep 30, 2014	10-K	2015-12-11
Q2 2014	-$4.18M	-$1.15M	-$652K	-132%	Apr 1, 2014	Jun 30, 2014	10-Q	2015-08-07
Q1 2014	-$3.53M	-$1.3M	-$1.17M	-921%	Jan 1, 2014	Mar 31, 2014	10-Q	2015-05-07
Q4 2013	-$2.36M	-$781K	-$619K	-382%	Oct 1, 2013	Dec 31, 2013	10-Q	2015-02-09
Q3 2013	-$1.74M	-$961K			Jul 1, 2013	Sep 30, 2013	10-K	2014-12-12
Q2 2013		-$495K	-$357K	-260%	Apr 1, 2013	Jun 30, 2013	10-Q	2014-08-06
Q1 2013		-$127K			Jan 1, 2013	Mar 31, 2013	10-Q	2014-05-15
Q4 2012		-$162K			Oct 1, 2012	Dec 31, 2012	10-Q	2014-02-14
Q2 2012		-$137K			Apr 1, 2012	Jun 30, 2012	10-Q	2013-08-14

* An asterisk sign (*) next to the value indicates that the value is likely invalid.